523 related articles for article (PubMed ID: 7946101)
1. Immunologic marker paths for seroconversion: single determinations of immunoglobulin A and beta 2-microglobulin are not adequate to estimate time of HIV infection. Multicohort Analysis Project Workshop. Part II.
AIDS; 1994 Jul; 8(7):923-33. PubMed ID: 7946101
[TBL] [Abstract][Full Text] [Related]
2. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
[TBL] [Abstract][Full Text] [Related]
3. CD4 surveillance in Scotland: perspectives on severe HIV-related immunodeficiency. CD4 Collaborative Group.
AIDS; 1997 Oct; 11(12):1509-17. PubMed ID: 9342074
[TBL] [Abstract][Full Text] [Related]
4. Use of beta 2-microglobulin level and CD4 lymphocyte count to predict development of acquired immunodeficiency syndrome in persons with human immunodeficiency virus infection.
Anderson RE; Lang W; Shiboski S; Royce R; Jewell N; Winkelstein W
Arch Intern Med; 1990 Jan; 150(1):73-7. PubMed ID: 1967523
[TBL] [Abstract][Full Text] [Related]
5. Serum beta 2-microglobulin level increases in HIV infection: relation to seroconversion, CD4 T-cell fall and prognosis.
Hofmann B; Wang YX; Cumberland WG; Detels R; Bozorgmehri M; Fahey JL
AIDS; 1990 Mar; 4(3):207-14. PubMed ID: 1972020
[TBL] [Abstract][Full Text] [Related]
6. Improvement of the predictive value of CD4+ lymphocyte count by beta 2-microglobulin, immunoglobulin A and erythrocyte sedimentation rate. The Multicentre Cohort Study Group.
Schwartländer B; Bek B; Skarabis H; Koch J; Burkowitz J; Koch MA
AIDS; 1993 Jun; 7(6):813-21. PubMed ID: 8103341
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
[TBL] [Abstract][Full Text] [Related]
8. HIV infection in women: immunological markers and the influence of pregnancy.
Brettle RP; Raab GM; Ross A; Fielding KL; Gore SM; Bird AG
AIDS; 1995 Oct; 9(10):1177-84. PubMed ID: 8519455
[TBL] [Abstract][Full Text] [Related]
9. [Natural history of human immunodeficiency virus infection in a cohort of Chilean patients].
Vial PA; Ferreccio C; Abarca K; Ortiz E; Noriega M; Pérez C; Labarca J; Torres M; Ferrés M; González C; Acuña G
Rev Med Chil; 1996 May; 124(5):525-35. PubMed ID: 9035503
[TBL] [Abstract][Full Text] [Related]
10. Disease progression and early predictors of AIDS in HIV-seroconverted injecting drug users. The Italian Seroconversion Study.
AIDS; 1992 Apr; 6(4):421-6. PubMed ID: 1616637
[TBL] [Abstract][Full Text] [Related]
11. Use of monitored CD4 cell counts: predictions of the AIDS epidemic in Scotland: CD4 Collaborative Group.
AIDS; 1992 Feb; 6(2):213-22. PubMed ID: 1348418
[TBL] [Abstract][Full Text] [Related]
12. [Discriminative value for AIDS case of erythrocyte sedimentation rate, immunoglobulins IgA and IgM, and beta 2-microglobulin in combination with the CD4+ lymphocyte count].
Pérez de Oteyza C; Menéndez Martínez MA; Muro García R; Pérez Aznar C; Barberán López J
An Med Interna; 1998 Aug; 15(8):411-4. PubMed ID: 9780421
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV
N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191
[TBL] [Abstract][Full Text] [Related]
14. [Adenosine deaminase (ADA) and beta 2-microglobulin (beta 2M) as discriminating serum markers of progression to AIDS].
Pérez de Oteyza C; Menéndez Martínez MA; Irazábal C; Enríquez de Salamanca R; Pérez Aznar C; Rebollar JL
An Med Interna; 1996 May; 13(5):217-21. PubMed ID: 8767867
[TBL] [Abstract][Full Text] [Related]
15. Association between the rate of CD4+ T cell decrease and the year of human immunodeficiency virus (HIV) type 1 seroconversion among persons enrolled in the Swiss HIV cohort study.
Vanhems P; Lambert J; Guerra M; Hirschel B; Allard R
J Infect Dis; 1999 Dec; 180(6):1803-8. PubMed ID: 10558934
[TBL] [Abstract][Full Text] [Related]
16. Changes over time in post-seroconversion CD4 cell counts in the Italian HIV-Seroconversion Study: 1985-2002.
Dorrucci M; Phillips AN; Longo B; Rezza G;
AIDS; 2005 Feb; 19(3):331-5. PubMed ID: 15718844
[TBL] [Abstract][Full Text] [Related]
17. Characterization of GBV-C infection in HIV-1 infected patients.
Canducci F; Uberti Foppa C; Boeri E; Racca S; Gallotta G; Grasso MA; Calori G; Lazzarin A; Clementi M
J Biol Regul Homeost Agents; 2003; 17(2):191-4. PubMed ID: 14518722
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia.
Goedert JJ; Kessler CM; Aledort LM; Biggar RJ; Andes WA; White GC; Drummond JE; Vaidya K; Mann DL; Eyster ME
N Engl J Med; 1989 Oct; 321(17):1141-8. PubMed ID: 2477702
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with progression to AIDS and mortality in a cohort of HIV-infected patients with hemophilia followed up since seroconversion.
Santagostino E; Gringeri A; Cultraro D; Tradati F; Siracusano L; Marinoni A; Mannucci PM
Cell Mol Biol (Noisy-le-grand); 1995 May; 41(3):371-80. PubMed ID: 7580830
[TBL] [Abstract][Full Text] [Related]
20. Assessment of nutritional, clinical, and immunologic status of HIV-infected, inner-city patients with multiple risk factors.
Luder E; Godfrey E; Godbold J; Simpson DM
J Am Diet Assoc; 1995 Jun; 95(6):655-60. PubMed ID: 7759740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
